Basic Information
| RNALocate ID: | RLID:11001014 |
| RNA Symbol: | hsa-miR-29b-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-29b-3p |
| RNA ID: | miRBase:MIMAT0000100 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001443 | Cytoplasm | HeLa cells | 28185889 |
| RLID:01001444 | Cytoplasm | Hepatic carcinoma cells (Huh-7) | 29253196 |
| RLID:01001445 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001446 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001447 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001448 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001449 | Nucleus | Hela cells|NIH-3T3 cells | 17204650 |
| RLID:01001450 | Nucleus | HeLa cells | 28185889 |
| RLID:01001451 | Nucleus | Hepatic carcinoma cells (Huh-7) | 29253196 |
| RLID:01001452 | Nucleus | HeLa cells | 30006350 |
| RLID:01001453 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:11001009 | Exosome | Urine | 26576778 |
| RLID:11001010 | Exosome | HCC tissues | 30542726 |
| RLID:11001011 | Exosome | Saliva | 19627513 |
| RLID:11001012 | Exosome | B cell line (Raji)|Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001013 | Exosome | Brain tissue | 23382797 |
| RLID:11001015 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001016 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000034 | Exosome | Breast milk|Epithelial cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000299 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-29b-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-35224 |
| MNDR | hsa-miR-29b-3p | Oral squamous cell carcinoma | MNDR-E-MI-35225 |
| MNDR | hsa-miR-29b-3p | Large cell neuroendocrine cancer | MNDR-E-MI-35226 |
| MNDR | hsa-miR-29b-3p | Medulloblastoma | MNDR-E-MI-35227 |
| MNDR | hsa-miR-29b-3p | B cell lymphoma of malt type | MNDR-E-MI-35228 |
| MNDR | hsa-miR-29b-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-35229 |
| MNDR | hsa-miR-29b-3p | Ovarian clear cell carcinoma | MNDR-E-MI-35230 |
| MNDR | hsa-miR-29b-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-35231 |
| MNDR | hsa-miR-29b-3p | Spinocerebellar ataxia type 17 | MNDR-E-MI-35232 |
| MNDR | hsa-miR-29b-3p | Lymphoma | MNDR-E-MI-35233 |
| MNDR | hsa-miR-29b-3p | Non-hodgkin lymphoma | MNDR-E-MI-35234 |
| MNDR | hsa-miR-29b-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-35235 |
| MNDR | hsa-miR-29b-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-35236 |
| MNDR | hsa-miR-29b-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-35237 |
| MNDR | hsa-miR-29b-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-35238 |
| MNDR | hsa-miR-29b-3p | Her2-receptor positive breast cancer | MNDR-E-MI-35239 |
| MNDR | hsa-miR-29b-3p | Breast cancer luminal | MNDR-E-MI-35240 |
| MNDR | hsa-miR-29b-3p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-35241 |
| MNDR | hsa-miR-29b-3p | Prostate cancer | MNDR-E-MI-35242 |
| MNDR | hsa-miR-29b-3p | Chronic lymphocytic leukemia | MNDR-E-MI-35243 |
| MNDR | hsa-miR-29b-3p | Gastric cancer | MNDR-E-MI-35244 |
| MNDR | hsa-miR-29b-3p | Alzheimer disease | MNDR-E-MI-35245 |
| MNDR | hsa-miR-29b-3p | Intracranial aneurysm | MNDR-E-MI-35246 |
| MNDR | hsa-miR-29b-3p | Sarcoma | MNDR-E-MI-35247 |
| MNDR | hsa-miR-29b-3p | Dysautonomia familial | MNDR-E-MI-35248 |
| MNDR | hsa-miR-29b-3p | Myotonic dystrophy | MNDR-E-MI-35249 |
| MNDR | hsa-miR-29b-3p | Duchenne muscular dystrophy | MNDR-E-MI-35250 |
| MNDR | hsa-miR-29b-3p | Facioscapulohumeral muscular dystrophy | MNDR-E-MI-35251 |
| MNDR | hsa-miR-29b-3p | Primary biliary cirrhosis | MNDR-E-MI-35252 |
| MNDR | hsa-miR-29b-3p | Leukemia | MNDR-E-MI-35253 |
| MNDR | hsa-miR-29b-3p | Huntington disease | MNDR-E-MI-35254 |
| MNDR | hsa-miR-29b-3p | Chorea | MNDR-E-MI-35255 |
| MNDR | hsa-miR-29b-3p | Cardiovascular disease | MNDR-E-MI-35256 |
| MNDR | hsa-miR-29b-3p | Uterine fibroid | MNDR-E-MI-35257 |
| MNDR | hsa-miR-29b-3p | Lung cancer | MNDR-E-MI-35258 |
| MNDR | hsa-miR-29b-3p | Down syndrome | MNDR-E-MI-35259 |
| MNDR | hsa-miR-29b-3p | Parkinson disease | MNDR-E-MI-35260 |
| MNDR | hsa-miR-29b-3p | Basal-like breast cancer | MNDR-E-MI-35261 |
| MNDR | hsa-miR-29b-3p | Thyroid cancer | MNDR-E-MI-35262 |
| MNDR | hsa-miR-29b-3p | Pancreatic cancer | MNDR-E-MI-35263 |
| MNDR | hsa-miR-29b-3p | Melanoma | MNDR-E-MI-35264 |
| MNDR | hsa-miR-29b-3p | Rectum adenocarcinoma | MNDR-E-MI-35265 |
| MNDR | hsa-miR-29b-3p | Nephroblastoma | MNDR-E-MI-35266 |
| MNDR | hsa-miR-29b-3p | Colon cancer | MNDR-E-MI-35267 |
| MNDR | hsa-miR-29b-3p | Ischemic attack transient | MNDR-E-MI-35268 |
| MNDR | hsa-miR-29b-3p | Colon adenocarcinoma | MNDR-E-MI-35269 |
| MNDR | hsa-miR-29b-3p | West nile virus infection | MNDR-E-MI-35270 |
| MNDR | hsa-miR-29b-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-35271 |
| MNDR | hsa-miR-29b-3p | Prostate adenocarcinoma | MNDR-E-MI-35272 |
| MNDR | hsa-miR-29b-3p | Kidney cancer | MNDR-E-MI-35273 |
| MNDR | hsa-miR-29b-3p | Thyroid adenomas | MNDR-E-MI-35274 |
| MNDR | hsa-miR-29b-3p | Carcinoma ductal breast | MNDR-E-MI-35275 |
| MNDR | hsa-miR-29b-3p | Glioblastoma | MNDR-E-MI-35276 |
| MNDR | hsa-miR-29b-3p | Astrocytoma | MNDR-E-MI-35277 |
| MNDR | hsa-miR-29b-3p | Glioma | MNDR-E-MI-35278 |
| MNDR | hsa-miR-29b-3p | Nemaline myopathy | MNDR-E-MI-35279 |
| MNDR | hsa-miR-29b-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-35280 |
| MNDR | hsa-miR-29b-3p | Osteosarcoma | MNDR-E-MI-35281 |
| MNDR | hsa-miR-29b-3p | Liposarcoma | MNDR-E-MI-35282 |
| MNDR | hsa-miR-29b-3p | Meningioma | MNDR-E-MI-35283 |
| MNDR | hsa-miR-29b-3p | Uterine cancer | MNDR-E-MI-35284 |
| MNDR | hsa-miR-29b-3p | Stomach adenocarcinoma | MNDR-E-MI-35285 |
| MNDR | hsa-miR-29b-3p | Lung squamous cell carcinoma | MNDR-E-MI-35286 |
| MNDR | hsa-miR-29b-3p | Carcinoma lung non-small-cell | MNDR-E-MI-35287 |
| MNDR | hsa-miR-29b-3p | Lung adenocarcinoma | MNDR-E-MI-35288 |
| MNDR | hsa-miR-29b-3p | Adrenocortical cancer | MNDR-E-MI-35289 |
| MNDR | hsa-miR-29b-3p | Thyroid carcinoma | MNDR-E-MI-35290 |
| MNDR | hsa-miR-29b-3p | Papillary thyroid carcinoma | MNDR-E-MI-35291 |
| MNDR | hsa-miR-29b-3p | Ovarian carcinoma | MNDR-E-MI-35292 |
| MNDR | hsa-miR-29b-3p | Bladder urothelial carcinoma | MNDR-E-MI-35293 |
| MNDR | hsa-miR-29b-3p | Pancreatic adenocarcinoma | MNDR-E-MI-35294 |
| MNDR | hsa-miR-29b-3p | Brain stem cancer | MNDR-E-MI-35295 |
| MNDR | hsa-miR-29b-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-35296 |
| MNDR | hsa-miR-29b-3p | Carcinoma renal cell | MNDR-E-MI-35297 |
| MNDR | hsa-miR-29b-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-35298 |
| MNDR | hsa-miR-29b-3p | Renal clear cell carcinoma | MNDR-E-MI-35299 |
| MNDR | hsa-miR-29b-3p | Cholangiocarcinoma | MNDR-E-MI-35300 |
| MNDR | hsa-miR-29b-3p | Esophageal cancer | MNDR-E-MI-35301 |
| MNDR | hsa-miR-29b-3p | Oncocytoma | MNDR-E-MI-35302 |
| MNDR | hsa-miR-29b-3p | Lung small cell carcinoma | MNDR-E-MI-35303 |
| MNDR | hsa-miR-29b-3p | Schizophrenia | MNDR-E-MI-35304 |
| MNDR | hsa-miR-29b-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-35305 |
| MNDR | hsa-miR-29b-3p | Testicular germ cell cancer | MNDR-E-MI-35306 |
| MNDR | hsa-miR-29b-3p | Breast invasive carcinoma | MNDR-E-MI-35307 |
| MNDR | hsa-miR-29b-3p | Hepatocellular carcinoma | MNDR-E-MI-35308 |
| MNDR | hsa-miR-29b-3p | Aggressive b-cell lymphoma | MNDR-E-MI-35309 |
| MNDR | hsa-miR-29b-3p | Rheumatoid arthritis | MNDR-E-MI-35310 |
| MNDR | hsa-miR-29b-3p | T-cell leukemia | MNDR-E-MI-35311 |
| MNDR | hsa-miR-29b-3p | Retinoblastoma | MNDR-E-MI-35312 |
| MNDR | hsa-miR-29b-3p | Neuroblastoma | MNDR-E-MI-35313 |
| MNDR | hsa-miR-29b-3p | Barrett's adenocarcinoma | MNDR-E-MI-35314 |
| MNDR | hsa-miR-29b-3p | Chronic myelogenous leukemia | MNDR-E-MI-35315 |
| MNDR | hsa-miR-29b-3p | Hodgkin lymphoma | MNDR-E-MI-35316 |
| MNDR | hsa-miR-29b-3p | Burkitt lymphoma | MNDR-E-MI-35317 |
| MNDR | hsa-miR-29b-3p | Tonsil cancer | MNDR-E-MI-35318 |
| MNDR | hsa-miR-29b-3p | Neuromyelitis optica | MNDR-E-MI-35319 |
| MNDR | hsa-miR-29b-3p | Acute myeloid leukemia | MNDR-E-MI-35320 |
| MNDR | hsa-miR-29b-3p | Frontotemporal dementia | MNDR-E-MI-35321 |
| MNDR | hsa-miR-29b-3p | Colorectal cancer | MNDR-E-MI-35322 |
| MNDR | hsa-miR-29b-3p | Nasopharynx carcinoma | MNDR-E-MI-35323 |
| MNDR | hsa-miR-29b-3p | Type 2 diabetes | MNDR-E-MI-35324 |
| MNDR | hsa-miR-29b-3p | Multiple myeloma | MNDR-E-MI-35325 |
| MNDR | hsa-miR-29b-3p | Ependymoma | MNDR-E-MI-35326 |
| MNDR | hsa-miR-29b-3p | Cardiomegaly | MNDR-E-MI-35327 |
| MNDR | hsa-miR-29b-3p | Nasopharyngeal cancer | MNDR-E-MI-35328 |
| MNDR | hsa-miR-29b-3p | Prostatic neoplasms | MNDR-E-MI-35329 |
| MNDR | hsa-miR-29b-3p | Acute myelogeneous leukemia | MNDR-E-MI-35330 |
| MNDR | hsa-miR-29b-3p | Aids dementia complex | MNDR-E-MI-35331 |
| MNDR | hsa-miR-29b-3p | Epstein-barr virus infections | MNDR-E-MI-35332 |
| MNDR | hsa-miR-29b-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-35333 |
| MNDR | hsa-miR-29b-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-35334 |
| MNDR | hsa-miR-29b-3p | Stroke lacunar | MNDR-E-MI-35335 |
| MNDR | hsa-miR-29b-3p | Non-alcoholic fatty liver disease | MNDR-E-MI-35336 |
| MNDR | hsa-miR-29b-3p | Barrett's carcinogenesis | MNDR-E-MI-35337 |
| MNDR | hsa-miR-29b-3p | Breast cancer her3+ negative | MNDR-E-MI-35338 |
| MNDR | hsa-miR-29b-3p | Limb-girdle muscular dystrophies types 2A | MNDR-E-MI-35339 |
| MNDR | hsa-miR-29b-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-35340 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACVR2A | Homo sapiens | RR00039275 |
TOP